Pooled analysis of large and long-term safety data from the human papillomavirus-16/18-AS04-adjuvanted vaccine clinical trial programme

অনুরূপ উপাদানগুলি

• Post-licensure safety surveillance for human papillomavirus-16/18-AS04-adjuvanted vaccine: more than 4 years of experience
  অনুযায়ী: Angelo, Maria-Genalin, অন্যান্য
  প্রকাশিত: (2014)
• Risk of new onset autoimmune disease in 9- to 25-year-old women exposed to human papillomavirus-16/18 AS04-adjuvanted vaccine in the United Kingdom
  অনুযায়ী: Willame, Corinne, অন্যান্য
  প্রকাশিত: (2016)
• Safety of the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine in adolescents aged 12–15 years: Interim analysis of a large community-randomized controlled trial
  অনুযায়ী: Lehtinen, Matti, অন্যান্য
  প্রকাশিত: (2016)
• Safety of the AS04-adjuvanted human papillomavirus (HPV)-16/18 vaccine in adolescents aged 12–15 years: end-of-study results from a community-randomized study up to 6.5 years
  অনুযায়ী: Bi, Dan, অন্যান্য
  প্রকাশিত: (2019)
• Prevalence and Incidence of Human Papillomavirus (HPV) Infection Before and After Pregnancy: Pooled Analysis of the Control Arms of Efficacy Trials of HPV-16/18 AS04-Adjuvanted Vaccine
  অনুযায়ী: Chen, Jing, অন্যান্য
  প্রকাশিত: (2019)